T
T A Sellers
Researcher at University of South Florida
Publications - 19
Citations - 1009
T A Sellers is an academic researcher from University of South Florida. The author has contributed to research in topics: Cancer & Ovarian cancer. The author has an hindex of 9, co-authored 19 publications receiving 957 citations.
Papers
More filters
Journal ArticleDOI
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Zsofia Kote-Jarai,Olama Aaa.,G.G. Giles,G.G. Giles,Gianluca Severi,Gianluca Severi,Johanna Schleutker,Maren Weischer,Daniele Campa,Elio Riboli,Timothy J. Key,Henrik Grönberg,David J. Hunter,Peter Kraft,Michael J. Thun,Sue A. Ingles,Stephen J. Chanock,Stephen J. Chanock,Demetrius Albanes,Richard B. Hayes,David E. Neal,David E. Neal,Freddie C. Hamdy,Jenny L Donovan,Paul D.P. Pharoah,Fredrick R. Schumacher,Brian E. Henderson,Janet L. Stanford,Janet L. Stanford,Elaine A. Ostrander,Karina Dalsgaard Sørensen,Thilo Dörk,Gerald L. Andriole,Joanne L. Dickinson,Cezary Cybulski,Jan Lubinski,Amanda B. Spurdle,Judith A. Clements,Suzanne K. Chambers,Joanne F. Aitken,Gardiner Raf.,S. N. Thibodeau,D J Schaid,Esther M. John,Esther M. John,Christiane Maier,W. Vogel,Kathleen A. Cooney,Jong Y. Park,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,Hermann Brenner,Tomonori Habuchi,Zhang H-W.,Lu Y-J.,Radka Kaneva,Kenneth Muir,Sara Benlloch,Daniel Leongamornlert,Ed Saunders,Malgorzata Tymrakiewicz,N. Mahmud,Michelle Guy,Lynne T. O'Brien,R A Wilkinson,Amanda L. Hall,E J Sawyer,Tokhir Dadaev,Jonathan J. Morrison,David P. Dearnaley,David P. Dearnaley,Alan Horwich,Alan Horwich,Robert Huddart,Robert Huddart,Vincent Khoo,Vincent Khoo,Chris Parker,Chris Parker,N. van As,C.R.J. Woodhouse,A. Thompson,Timothy J. Christmas,Chris Ogden,Colin Cooper,Aritaya Lophatonanon,Melissa C. Southey,John L. Hopper,Dallas R. English,Dallas R. English,T. Wahlfors,Tammela Tlj.,Peter Klarskov,Børge G. Nordestgaard,Martin Andreas Røder,Anne Tybjærg-Hansen,Stig E. Bojesen,Ruth C. Travis,Federico Canzian,Rudolph Kaaks,Fredrik Wiklund,Markus Aly,Sara Lindström,W. R. Diver,Susan M. Gapstur,Mariana C. Stern,Roman Corral,Jarmo Virtamo,Angela Cox,Christopher A. Haiman,Loic Le Marchand,Liesel M. FitzGerald,Suzanne Kolb,Erika M. Kwon,Danielle M. Karyadi,Torben F. Ørntoft,Michael Borre,Andreas Meyer,Jürgen Serth,Meredith Yeager,Sonja I. Berndt,James R. Marthick,Briony Patterson,Dominika Wokołorczyk,Jyotsna Batra,Felicity Lose,Shannon K. McDonnell,Amit Joshi,A Shahabi,Antje E. Rinckleb,A Ray,T A Sellers,Lin H-Y.,Robert A. Stephenson,J. M. Farnham,Heiko Müller,Dietrich Rothenbacher,Norihiko Tsuchiya,Shintaro Narita,Cao G-W.,C. Slavov,Vanio Mitev,Douglas F. Easton,Rosalind A. Eeles,Rosalind A. Eeles +144 more
TL;DR: The results of stage 3 are reported, in which 1,536 SNPs are evaluated in 4,574 individuals with prostate cancer (cases) and 4,164 controls and a SNP in TERT more strongly associated with PrCa than that previously reported is identified.
Journal ArticleDOI
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Kelly L. Bolton,Kelly L. Bolton,Jonathan Tyrer,Honglin Song,Susan J. Ramus,Maria Notaridou,Chris Jones,Tanya Sher,Aleksandra Gentry-Maharaj,Eva Wozniak,Ya-Yu Tsai,Joanne B. Weidhaas,Daniel Paik,David Van Den Berg,Daniel O. Stram,Celeste Leigh Pearce,Anna H. Wu,Wendy R. Brewster,Hoda Anton-Culver,Argyrios Ziogas,Steven A. Narod,Douglas A. Levine,Stanley B. Kaye,Robert S. Brown,James Paul,James M. Flanagan,Weiva Sieh,Valerie McGuire,Alice S. Whittemore,Ian G. Campbell,Martin Gore,Jolanta Lissowska,Hanna P. Yang,Krzysztof Mędrek,Jacek Gronwald,Jan Lubinski,Anna Jakubowska,Nhu D. Le,Linda S. Cook,Linda S. Cook,Linda E. Kelemen,Angela Brook-Wilson,Angela Brook-Wilson,Leon F.A.G. Massuger,Lambertus A. Kiemeney,Katja K.H. Aben,Anne M. van Altena,Richard S. Houlston,Ian Tomlinson,Rachel T. Palmieri,Patricia G. Moorman,Joellen M. Schildkraut,Edwin S. Iversen,Catherine M. Phelan,Robert A. Vierkant,Julie M. Cunningham,Ellen L. Goode,Brooke L. Fridley,Susan Kruger-Kjaer,Jan Blaeker,Estrid Høgdall,Claus Høgdall,Jenny Gross,Beth Y. Karlan,Roberta B. Ness,Robert P. Edwards,Kunle Odunsi,Kirsten B. Moyisch,Julie A. Baker,Francesmary Modugno,Tuomas Heikkinenen,Ralf Bützow,Heli Nevanlinna,Arto Leminen,Natalia Bogdanova,Natalia Antonenkova,Thilo Doerk,Peter Hillemanns,Matthias Dürst,Ingo B. Runnebaum,Pamela J. Thompson,Michael E. Carney,Marc T. Goodman,Galina Lurie,Shan Wang-Gohrke,Rebecca Hein,Jenny Chang-Claude,Mary Anne Rossing,Kara L. Cushing-Haugen,Jennifer A. Doherty,Chu Chen,Thorunn Rafnar,Søren Besenbacher,Patrick Sulem,Kari Stefansson,Michael J. Birrer,Kathryn L. Terry,Dena G. Hernandez,Daniel W. Cramer,Ignace Vergote,Frédéric Amant,Diether Lambrechts,Evelyn Despierre,Peter A. Fasching,Matthias W. Beckmann,Falk Thiel,Arif B. Ekici,Xiaoqing Chen,Sharon E. Johnatty,Penelope M. Webb,Jonathan Beesley,Stephen J. Chanock,Montserrat Garcia-Closas,T A Sellers,Douglas F. Easton,Andrew Berchuck,Georgia Chenevix-Trench,Paul D.P. Pharoah,Simon A. Gayther +118 more
TL;DR: In this article, a three-phase genome-wide association study of EOC survival in 8,951 individuals with EOC (cases) with available survival time data and a parallel association analysis of susceptibility showed evidence of association with survival.
Journal ArticleDOI
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Ali Amin Al Olama,Zsofia Kote-Jarai,Fredrick R. Schumacher,Fredrik Wiklund,Sonja I. Berndt,S. Benlloch,Graham G. Giles,Graham G. Giles,Gianluca Severi,Gianluca Severi,David E. Neal,David E. Neal,Freddie C. Hamdy,Jenny L Donovan,David J. Hunter,B. E. Henderson,Michael J. Thun,Michael Gaziano,Michael Gaziano,Edward Giovannucci,Afshan Siddiq,Ruth C. Travis,David G. Cox,David G. Cox,Federico Canzian,Elio Riboli,Timothy J. Key,Gerald L. Andriole,Demetrius Albanes,Richard B. Hayes,Johanna Schleutker,Johanna Schleutker,Anssi Auvinen,Tammela Tlj.,Maren Weischer,Janet L. Stanford,Janet L. Stanford,Elaine A. Ostrander,Cezary Cybulski,Jan Lubinski,S. N. Thibodeau,D J Schaid,Karina Dalsgaard Sørensen,Jyotsna Batra,Judith A. Clements,Suzanne K. Chambers,Suzanne K. Chambers,Joanne F. Aitken,Robert A. Gardiner,Christiane Maier,W. Vogel,Thilo Dörk,Hermann Brenner,Tomonori Habuchi,Sue A. Ingles,Esther M. John,Esther M. John,Joanne L. Dickinson,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,Manuel R. Teixeira,Radka Kaneva,Zhang H-W.,Lu Y-J.,Jong Y. Park,Kathleen A. Cooney,Kenneth Muir,Daniel Leongamornlert,E. Saunders,Malgorzata Tymrakiewicz,N. Mahmud,Michelle Guy,K. Govindasami,Lynne T. O'Brien,R A Wilkinson,Amanda L. Hall,E J Sawyer,Tokhir Dadaev,Jonathan J. Morrison,David P. Dearnaley,Alan Horwich,Robert Huddart,Vincent Khoo,Chris Parker,N. van As,C.R.J. Woodhouse,A. Thompson,Tim Dudderidge,Chris Ogden,Colin Cooper,Aritaya Lophatonanon,Melissa C. Southey,John L. Hopper,Dallas R. English,Dallas R. English,Jarmo Virtamo,Loic Le Marchand,D Campa,Rudolph Kaaks,S. Lindstrom,W. R. Diver,Susan M. Gapstur,Meredith Yeager,Angela Cox,Mariana C. Stern,Roman Corral,Markus Aly,W. Isaacs,Jan Adolfsson,Jianfeng Xu,Siqun L. Zheng,T. Wahlfors,Kimmo Taari,Paula Kujala,Peter Klarskov,Børge G. Nordestgaard,Martin Andreas Røder,Ruth Frikke-Schmidt,Stig E. Bojesen,Liesel M. FitzGerald,Suzanne Kolb,Erika M. Kwon,Danielle M. Karyadi,Torben F. Ørntoft,Michael Borre,Antje E. Rinckleb,Manuel Luedeke,Kathleen Herkommer,Andreas Meyer,Jürgen Serth,James R. Marthick,Briony Patterson,Dominika Wokołorczyk,Amanda B. Spurdle,Felicity Lose,Shannon K. McDonnell,Amit Joshi,Ahva Shahabi,Pedro Vaz Pinto,João Vasco Santos,Anna M. Ray,T A Sellers,Lin H-Y.,Robert A. Stephenson,Craig C. Teerlink,Heiko Müller,Dietrich Rothenbacher,Norihiko Tsuchiya,Shintaro Narita,Cao G-W.,C. Slavov,Vanio Mitev,S. J. Chanock,Henrik Grönberg,Christopher A. Haiman,Peter Kraft,Doug Easton,Rosalind A. Eeles +157 more
TL;DR: In this article, the authors conducted a meta-analysis of four GWAS including 5953 cases of aggressive prostate cancer and 11 463 controls (men without PrCa) and computed association tests for approximately 2.6 million SNPs and followed up the most significant SNPs by genotyping 49 121 samples through the international PRACTICAL and BPC3 consortia.
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Ali Amin Al Olama,Zsofia Kote-Jarai,Fredrick R. Schumacher,Fredrik Wiklund,Sonja I. Berndt,S. Benlloch,Graham G. Giles,Gianluca Severi,David E. Neal,Freddie C. Hamdy,Jenny L Donovan,David J. Hunter,B. E. Henderson,Michael J. Thun,Michael Gaziano,Edward Giovannucci,A. Siddiq,Ruth C. Travis,David G. Cox,Federico Canzian,Elio Riboli,Timothy J. Key,Gerald L. Andriole,Demetrius Albanes,Richard B. Hayes,Johanna Schleutker,Anssi Auvinen,Teuvo L.J. Tammela,Maren Weischer,Janet L. Stanford,Elaine A. Ostrander,Cezary Cybulski,Jan Lubinski,S. N. Thibodeau,D J Schaid,Karina Dalsgaard Sørensen,Jyotsna Batra,Judith A. Clements,Suzanne K. Chambers,Joanne F. Aitken,Robert A. Gardiner,Christiane Maier,W. Vogel,Thilo Dörk,Hermann Brenner,Tomonori Habuchi,Sue A. Ingles,Esther M. John,Joanne L. Dickinson,Lisa A. Cannon-Albright,Manuel R. Teixeira,Radka Kaneva,Hong Wei Zhang,Yong-Jie Lu,Jong Y. Park,Kathleen A. Cooney,Kenneth Muir,Daniel Leongamornlert,E. Saunders,Malgorzata Tymrakiewicz,N. Mahmud,Michelle Guy,K. Govindasami,Lynne T. O'Brien,R A Wilkinson,Amanda L. Hall,E J Sawyer,Tokhir Dadaev,Jonathan J. Morrison,David P. Dearnaley,Alan Horwich,Robert Huddart,Vincent Khoo,Chris Parker,N. van As,C.R.J. Woodhouse,Alan J. Thompson,Tim Dudderidge,Chris Ogden,Colin Cooper,Aritaya Lophatonanon,Melissa C. Southey,John L. Hopper,Dallas R. English,Jarmo Virtamo,Loic Le Marchand,D. Campa,Rudolph Kaaks,S. Lindstrom,W. R. Diver,Susan M. Gapstur,M. Yeager,Angela Cox,Mariana C. Stern,Roman Corral,M. Aly,W. Isaacs,Jan Adolfsson,Jianfeng Xu,Siqun L. Zheng,T. Wahlfors,Kimmo Taari,Paula Kujala,Peter Klarskov,Børge G. Nordestgaard,Roder,Ruth Frikke-Schmidt,S.E. Bojesen,Liesel M. FitzGerald,Suzanne Kolb,Erika M. Kwon,Danielle M. Karyadi,Torben F. Ørntoft,Michael Borre,Antje E. Rinckleb,Manuel Luedeke,Kathleen Herkommer,Andreas Meyer,Jürgen Serth,James R. Marthick,Briony Patterson,Dominika Wokołorczyk,Amanda B. Spurdle,Felicity Lose,Shannon K. McDonnell,Amit Joshi,Ahva Shahabi,Pedro Vaz Pinto,João Vasco Santos,Anna M. Ray,T A Sellers,Hui-Yi Lin,Robert A. Stephenson,Craig C. Teerlink,Müller H,Dietrich Rothenbacher,Norihiko Tsuchiya,Shintaro Narita,Guangwen Cao,C. Slavov,V. Mitev,S. J. Chanock,Henrik Grönberg,Christopher A. Haiman,Peter Kraft,Doug Easton,Rosalind A. Eeles +146 more
TL;DR: In this article, the authors conducted a meta-analysis of four GWAS including 5953 cases of aggressive prostate cancer and 11 463 controls (men without PrCa) and computed association tests for approximately 2.6 million SNPs and followed up the most significant SNPs by genotyping 49 121 samples through the international PRACTICAL and BPC3 consortia.
Journal ArticleDOI
Prediction of individual genetic risk to prostate cancer using a polygenic score.
Robert Szulkin,Tom Whitington,Martin Eklund,Markus Aly,Rosalind A. Eeles,Rosalind A. Eeles,Douglas F. Easton,Zsofia Kote-Jarai,Ali Amin Al Olama,Sara Benlloch,Kenneth Muir,Kenneth Muir,G.G. Giles,G.G. Giles,Melissa C. Southey,Liesel M. FitzGerald,B. E. Henderson,Fredrick R. Schumacher,Christopher A. Haiman,Johanna Schleutker,Johanna Schleutker,Tiina Wahlfors,Tammela Tlj.,Børge G. Nordestgaard,Børge G. Nordestgaard,Timothy J. Key,Ruth C. Travis,David E. Neal,Jenny L Donovan,Freddie C. Hamdy,Paul D.P. Pharoah,Nora Pashayan,Nora Pashayan,Khaw K-T.,Janet L. Stanford,Janet L. Stanford,S. N. Thibodeau,Shannon K. McDonnell,D J Schaid,Christiane Maier,W. Vogel,Manuel Luedeke,Kathleen Herkommer,Adam S. Kibel,Cezary Cybulski,Jan Lubinski,Wojciech Kluźniak,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,Hermann Brenner,Katja Butterbach,C. Stegmaier,Jong Y. Park,T A Sellers,Lin H-Y.,C. Slavov,Radka Kaneva,Vanio Mitev,Jyotsna Batra,Judith A. Clements,Amanda B. Spurdle,Manuel R. Teixeira,Paula Paulo,Sofia Maia,Hardev Pandha,Agnieszka Michael,Andrzej M. Kierzek,Henrik Grönberg,Fredrik Wiklund +68 more
TL;DR: Polygenic risk scores comprising established susceptibility variants have shown to be informative classifiers for several complex diseases including prostate cancer, but it is unknown if inclusion of genetic markers that have so far not been associated with prostate cancer risk at a genome‐wide significant level will improve disease prediction.